These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 28179398)

  • 1. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Lindahl B; Baron T; Erlinge D; Hadziosmanovic N; Nordenskjöld A; Gard A; Jernberg T
    Circulation; 2017 Apr; 135(16):1481-1489. PubMed ID: 28179398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of secondary prevention medical therapies on outcomes of patients suffering from Myocardial Infarction with NonObstructive Coronary Artery disease (MINOCA): A meta-analysis.
    De Filippo O; Russo C; Manai R; Borzillo I; Savoca F; Gallone G; Bruno F; Ahmad M; De Ferrari GM; D'Ascenzo F
    Int J Cardiol; 2022 Dec; 368():1-9. PubMed ID: 35987312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Secondary Prevention Medication on the Prognosis in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Abdu FA; Liu L; Mohammed AQ; Xu B; Yin G; Xu S; Xu Y; Che W
    J Cardiovasc Pharmacol; 2020 Dec; 76(6):678-683. PubMed ID: 33284169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease.
    Paolisso P; Bergamaschi L; Saturi G; D'Angelo EC; Magnani I; Toniolo S; Stefanizzi A; Rinaldi A; Bartoli L; Angeli F; Donati F; Rucci P; Mattioli AV; Taglieri N; Pizzi C; Galiè N
    Front Pharmacol; 2019; 10():1606. PubMed ID: 32082147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis and Predictors of Mortality in Patients Suffering Myocardial Infarction With Non-Obstructive Coronary Arteries.
    Choo EH; Chang K; Lee KY; Lee D; Kim JG; Ahn Y; Kim YJ; Chae SC; Cho MC; Kim CJ; Kim HS; Jeong MH;
    J Am Heart Assoc; 2019 Jul; 8(14):e011990. PubMed ID: 31284804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
    Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Appropriate secondary prevention and clinical outcomes after acute myocardial infarction according to atherothrombotic risk stratification: The FAST-MI 2010 registry.
    Tea V; Bonaca M; Chamandi C; Iliou MC; Lhermusier T; Aissaoui N; Cayla G; Angoulvant D; Ferrières J; Schiele F; Simon T; Danchin N; Puymirat E;
    Eur J Prev Cardiol; 2019 Mar; 26(4):411-419. PubMed ID: 30354737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal secondary prevention medication use in acute myocardial infarction patients with nonobstructive coronary artery disease is modified by management strategy: insights from the TRIUMPH Registry.
    Pitts R; Daugherty SL; Tang F; Jones P; Ho PM; Tsai TT; Spertus J; Maddox TM
    Clin Cardiol; 2017 Jun; 40(6):347-355. PubMed ID: 28387960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
    Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
    J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Medication Use in Patients with Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease.
    Adatia F; Galway S; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
    J Womens Health (Larchmt); 2017 Nov; 26(11):1185-1192. PubMed ID: 28384014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
    Figtree GA; Vernon ST; Hadziosmanovic N; Sundström J; Alfredsson J; Arnott C; Delatour V; Leósdóttir M; Hagström E
    Lancet; 2021 Mar; 397(10279):1085-1094. PubMed ID: 33711294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry.
    Ciliberti G; Verdoia M; Merlo M; Zilio F; Vatrano M; Bianco F; Mancone M; Zaffalon D; Bonci A; Boscutti A; Infusino F; Coiro S; Stronati G; Tritto I; Gioscia R; Dello Russo A; Fedele F; Gallina S; Cassadonte F; Ambrosio G; Bonmassari R; De Luca G; Sinagra G; Capucci A; Kaski JC; Guerra F
    Int J Cardiol; 2021 Mar; 327():9-14. PubMed ID: 33242505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
    BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design.
    Nordenskjöld AM; Agewall S; Atar D; Baron T; Beltrame J; Bergström O; Erlinge D; Gale CP; López-Pais J; Jernberg T; Johansson P; Ravn-Fisher A; Reynolds HR; Somaratne JB; Tornvall P; Lindahl B
    Am Heart J; 2021 Jan; 231():96-104. PubMed ID: 33203618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.
    Xie JX; Gunzburger EC; Kaun L; Plomondon ME; Barón AE; Waldo SW; Virani SS; Maddox TM; Mavromatis K
    Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e005455. PubMed ID: 31665896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A; Alexander JH; Hafley GE; Graham SH; Mehta RH; Mack MJ; Wolf RK; Cohn LH; Kouchoukos NT; Harrington RA; Gennevois D; Gibson CM; Califf RM; Ferguson TB; Peterson ED;
    Ann Thorac Surg; 2007 Mar; 83(3):993-1001. PubMed ID: 17307447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and β-blockers after coronary artery bypass graft surgery.
    Kalavrouziotis D; Buth KJ; Cox JL; Baskett RJ
    Am Heart J; 2011 Nov; 162(5):836-43. PubMed ID: 22093199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal Medical Therapy on Top of Dual-Antiplatelet Therapy: 1-Year Clinical Outcome in Patients With Acute Coronary Syndrome: The START Antiplatelet Registry.
    Cirillo P; Di Serafino L; Taglialatela V; Calabrò P; Antonucci E; Gresele P; Palareti G; Patti G; Pengo V; Pignatelli P; Marcucci R
    Angiology; 2020 Mar; 71(3):235-241. PubMed ID: 31867981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Events After Discontinuation of β-Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction: A Cohort Study on the French Healthcare Databases.
    Neumann A; Maura G; Weill A; Alla F; Danchin N
    Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004356. PubMed ID: 29653999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidity and cause-specific mortality in first-time myocardial infarction with nonobstructive coronary arteries.
    Eggers KM; Hjort M; Baron T; Jernberg T; Nordenskjöld AM; Tornvall P; Lindahl B
    J Intern Med; 2019 Apr; 285(4):419-428. PubMed ID: 30474313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.